Stock_Titan Posted - 1 day ago

$HCM HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda https://www.stocktitan.net/news/HCM/hutchmed-announces-positive-chmp-opinion-for-fruquintinib-in-6ts561554xjh.html

Doozio Posted - 2 weeks ago

$HCM a 🧠👀 is now 🧠⏰.

Stock_Titan Posted - 3 weeks ago

$HCM HUTCHMED Highlights Data to be Presented at AACR Congress 2024 https://www.stocktitan.net/news/HCM/hutchmed-highlights-data-to-be-presented-at-aacr-congress-c7yprxuyjcn4.html

Stock_Titan Posted - 3 weeks ago

$HCM HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status https://www.stocktitan.net/news/HCM/hutchmed-and-innovent-jointly-announce-nda-acceptance-in-china-for-hbfj0chz8qhu.html

Stock_Titan Posted - 4 weeks ago

$HCM HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC https://www.stocktitan.net/news/HCM/hutchmed-announces-savolitinib-s-nda-accepted-in-china-for-treatment-8308r1v9brqw.html

OpenOutcrier Posted - 1 month ago

$HCM (-1.6% pre) HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China https://ooc.bz/l/28437

DailyStocksPicks Posted - 1 month ago

Today's Oversold Stock #2: Summit Therapeutics ($SMMT): Financially, the company faces challenges with a substantial loss against small yearly sales, yet it has seen interest from major investors and shows some promise for long-term investment despite the high risk. The recent sell-off might suggest the stock is oversold, reflecting immediate financial concerns over potential future success. $ARVN, $MLTX, $INDV, $HCM For Detailed https://youtu.be/kiXj5yPn9rc

Stock_Titan Posted - 1 month ago

$HCM HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China https://www.stocktitan.net/news/HCM/hutchmed-initiates-registration-stage-of-the-eslim-02-phase-ii-iii-z1wiydihtrhj.html

DailyStocksPicks Posted - 1 month ago

Today's Oversold Stock #2: Summit Therapeutics ($SMMT): Summit Therapeutics' rollercoaster stock performance raises eyebrows. With a significant sales-to-loss ratio and a towering debt, what could possibly attract big investors like Vanguard and Goldman Sachs? Is the market's reaction justified, or are we missing a piece of the puzzle? Join us as we explore the intricacies of $SMMT's financials and market potential. Don’t miss this eye-opening analysis. $ARVN, $MLTX, $INDV, $HCM For Detailed $SMMT Analysis Watch: https://youtu.be/Rp7HXX5q-1I

Aigner_Andreas Posted - 02/29/24

#DeathCross $HCM at 15.21 R9 HiLo 47% T1Y 29 buy 1.9 DIV N/A #HUTCHMED #stocks #trading #finance #market

Ninja_Tradez Posted - 02/28/24

📢 $HCM - HUTCHMED Reports 2023 Full Year Results and Provides Business Updates https://newsfilter.io/a/155d606c24af7c196fbb3d7327b8454e

Stock_Titan Posted - 02/28/24

$HCM HUTCHMED Reports 2023 Full Year Results and Provides Business Updates https://www.stocktitan.net/news/HCM/hutchmed-reports-2023-full-year-results-and-provides-business-8sf40b4f0uuk.html

Stock_Titan Posted - 2 months ago

$HCM HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session https://www.stocktitan.net/news/HCM/hutchmed-highlights-presentation-of-phase-iii-data-on-fruquintinib-s9s486a6lxoi.html

CharlesTrevino865 Posted - 2 months ago

$HCM Hutchison China MediTech's notable presence in the healthcare sector has garnered interest. Concurrently, it's a good moment to delve into the performance of STLNF and evaluate its standing in your portfolio.

Skrumpa Posted - 2 months ago

$HCM Shorted at 12.09

TalkMarkets Posted - 2 months ago

Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets $SNY $HCM $GRCL https://talkmarkets.com/content/global-markets/week-in-review-shanghai-inmagene-signs-230-million-deal-to-develop-two-hutchmed-immunology-assets?post=430414&userid=123969

mrbucket Posted - 2 months ago

$HCM pity this great company is suffering from the "china" syndrome

Skrumpa Posted - 01/30/24

$HCM Short at 12.62

DonCorleone77 Posted - 01/30/24

$HCM 2 of 2 - Hutchmed announces marketing approval of Elunate in Hong Kong ....if they have supporting local clinical data and recognition from relevant experts, when they have been approved by only one reference drug regulatory authority. Hutchmed submitted the application based on the approval of Elunate from the China National Medical Products Administration, or NMPA, supported with local clinical data. Fruquintinib was also approved by the FDA in November 2023.

DonCorleone77 Posted - 01/30/24

$HCM 1 of 2 - Hutchmed announces marketing approval of Elunate in Hong Kong Hutchmed announced that the marketing approval of Elunate by the Pharmacy and Poisons Board of Hong Kong for the treatment of adult patients with previously treated metastatic colorectal cancer, or CRC. Elunate is a selective oral inhibitor of vascular endothelial growth factor, or VEGF, receptors -1, -2 and -3, which play a pivotal role in blocking tumor angiogenesis. This marks the first medicine to be approved under the new mechanism for registration of new drugs announced by the Government of the Hong Kong Special Administrative Region in October last year. The mechanism officially commenced on November 1, 2023. It allows drugs which are beneficial for treatment of life-threatening or severely debilitating diseases to apply for registration for use in Hong Kong....

Aigner_Andreas Posted - 3 months ago

TD BUY $HCM at 13.14, Supp 13.14 Resis 16.61 R26 HiLo 25% T1Y 29 buy 1.9 DIV N/A #HUTCHMED #stocks #trading #finance #market

mrbucket Posted - 3 months ago

$HCM this is getting hammered

tickeron Posted - 3 months ago

Is this good for your portfolio? $HCM price may climb as it broke lower Bollinger Band. View odds of downtrend. https://srnk.us/go/4974461

tickeron Posted - 3 months ago

A.I.dvisor made a bearish call on $HCM, netting in a 15.10% gain over 1 month https://srnk.us/go/4970102

tickeron Posted - 3 months ago

If you have $HCM or $HGV or $SCM in your portfolio, pay attention! https://srnk.us/go/4969080

risenhoover Posted - 3 months ago

$HCM / HUTCHMED files form 6-K https://fintel.io/doc/sec-hutchmed-china-ltd-1648257-6k-2024-january-11-19733-4685?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

DonCorleone77 Posted - 3 months ago

$HCM Hutchmed announces NDA acceptance in China for sovleplenib Hutchmed announced that the New Drug Application for sovleplenib for the treatment of adult patients with primary immune thrombocytopenia has been accepted for review and granted priority review by the China National Medical Products Administration. Sovleplenib is a novel, selective, oral inhibitor targeting spleen tyrosine kinase, being developed for the treatment of hematological malignancies and immune diseases. The NDA is supported by data from ESLIM-01, a randomized, double-blinded, placebo-controlled Phase III trial in China of sovleplenib in 188 adult patients with primary ITP who have received at least one prior line of standard therapy. In August 2023, HUTCHMED announced that the trial had met its primary endpoint of demonstrating a clinically meaningful and a statistically significant increase in durable response rate in patients treated with sovleplenib as compared to patients treated with placebo....

Stock_Titan Posted - 3 months ago

$HCM HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status https://www.stocktitan.net/news/HCM/hutchmed-announces-nda-acceptance-in-china-for-sovleplenib-for-the-0ym877i7dy8m.html

tickeron Posted - 3 months ago

Good move or bad move? $HCM price may climb as it broke lower Bollinger Band. View odds of downtrend. https://srnk.us/go/4964560

tickeron Posted - 3 months ago

$HCM vs. $HGV vs. $SCM: what will be the best investment? https://srnk.us/go/4962562